{"id":"W2466587609","doi":"10.14785/lymphosign-2016-0005","title":"A clinical trial protocol for the study of intravenous immunoglobulin in patients with primary antibody immunodeficiency disorders","year":2016,"lang":"en","type":"article","venue":"LymphoSign Journal","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Protocol (science); Primary immunodeficiency; Antibody; Guideline; Clinical trial; Immunodeficiency; Common variable immunodeficiency; Immunology; Intensive care medicine; Internal medicine; Alternative medicine; Immune system; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0363118,0.004043783,0.004085853,0.001705914,0.00436009,0.003274181,0.002366176,0.007381751,0.1143824],"category_scores_gemma":[0.04585518,0.00199722,0.002655108,0.002390767,0.002419081,0.003350903,0.001691709,0.01006868,0.02308295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003742776,"about_ca_system_score_gemma":0.01650061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007785336,"about_ca_topic_score_gemma":0.003232893,"domain_scores_codex":[0.9716579,0.01906756,0.003987663,0.001532375,0.002223931,0.001530593],"domain_scores_gemma":[0.9739208,0.00882183,0.004004607,0.004786745,0.005739615,0.0027263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2877847,0.01427892,0.001841606,0.0331982,0.001791404,0.001945148,0.00179957,0.003665267,0.01048883,0.05661242,0.3960957,0.1904983],"study_design_scores_gemma":[0.2598027,0.02083437,0.006205485,0.01223045,0.0007347756,0.001041788,0.0003579112,0.005167384,0.002700397,0.01650379,0.6741154,0.0003055281],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.001391508,0.0005955955,0.007999569,0.001311989,0.001410067,0.9762328,0.00351268,0.0002825631,0.007263246],"genre_scores_gemma":[0.003262092,0.0003675768,0.008064893,0.001218371,0.0003819784,0.9831018,0.001294819,0.00002125003,0.00228734],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.1143824,"threshold_uncertainty_score":0.3826471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01640184172148456,"score_gpt":0.3071716411319765,"score_spread":0.290769799410492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}